Stay updated with breaking news from Tidepool Loop. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PARSIPPANY, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial
The top 10 most popular FDA approval articles from the first quarter of 2023, with an additional spotlight on other top regulatory news from the first 3 months of the year.
The FDA has cleared Tidepool Loop, an automated insulin dosing mobile application to help manage type 1 diabetes.
The Tidepool Loop app connects to compatible continuous glucose monitors and pumps and helps Type 1 diabetes patients determine whether insulin levels should be adjusted.
Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older.